HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection

Abstract : Infection with Trypanosoma cruzi develops in three phases: acute, indeterminate or asymptomatic, and chronic phase (with cardiac or digestive manifestations). Moreover, transmission may occur from infected mothers to newborn, the so-called congenital form. In the present study, humoral responses against T. cruzi total extract and against the 13 amino acid peptide named R-13 derived from the parasite ribosomal P protein, previously described as a possible marker of chronic Chagas heart disease, were determined in chagasic patients and in blood bank donors from endemic areas. While in sera from acute phase, only IgM anti-T.cruzi response was observed, both IgM and IgG anti-T. cruzi antibodies were detected in sera from congenitally infected newborns. The percentage of positive response in sera from blood bank donors was relatively high in endemic regions. Antibodies against the R-13 peptide were present in a large proportion of cardiac chagasic patients but were totally lacking in patients with digestive form of Chagas' disease. Furthermore, anti-R-13 positive responses were detected in congenitally infected newborns.
Document type :
Journal articles
Complete list of metadata

Contributor : Christine Chevalier Connect in order to contact the contributor
Submitted on : Wednesday, May 19, 2021 - 11:55:52 AM
Last modification on : Thursday, April 7, 2022 - 10:10:29 AM

Links full text




Christine Aznar, Pablo Lopez-Bergami, Silvia Brandariz, Christine Chevalier, Pascale Liegeard, et al.. Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection. FEMS Immunology and Medical Microbiology, Wiley-Blackwell: No OnlineOpen, 1995, 12 (3-4), pp.231-237. ⟨10.1111/j.1574-695X.1995.tb00197.x⟩. ⟨pasteur-03229841⟩



Record views